相关实验视频
Updated: Aug 9, 2026

12:12
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Published on: June 16, 2011
在I型糖尿病中补充固定的小岛细胞抗体:可能监测活性β细胞损伤的监测器
Lancet (London, England)
|March 29, 1980
概括
补充固定的小岛细胞抗体与1型糖尿病发病和β细胞损伤有关. 这些抗体可能是研究1型糖尿病进展的更好的标志物,而不是传统的小岛细胞抗体.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 糖尿病学 糖尿病学
背景情况:
- 1型糖尿病是一种自身免疫性疾病,其特征是破坏胰腺β细胞.
- 岛屿细胞抗体被用作1型糖尿病的标记物,但它们的确切作用和预测价值仍在研究中.
研究的目的:
- 调查补充固定的小岛细胞抗体的存在和重要性.
- 为了比较补充固定小岛细胞抗体与常规小岛细胞抗体在1型糖尿病中的临床相关性.
主要方法:
- 分析1型糖尿病患者,非糖尿病多分泌患者和1型糖尿病患者的亲属血清样本.
- 检测补充固定小岛细胞抗体和常规小岛细胞抗体.
主要成果:
- 发现了不同种类的补体固定小岛细胞抗体的证据.
- 补充固定的小岛细胞抗体与临床疾病发病的相关性更强,并且比传统抗体更快地消失.
- 这些抗体可能有选择性地表明胰腺β细胞受损.
结论:
- 补充固定的小岛细胞抗体代表了一个独特的实体,可能反映出β细胞损伤.
- 与传统的小岛细胞抗体相比,它们可以作为研究1型糖尿病自然史的优质血清标记物.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

